Showing 1 posts of 1 posts found.
Eisai’s injectible breast cancer drug Halaven has been approved by European regulators. The highly novel drug is made from a …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO